Suowen Xu

35.0k total citations · 9 hit papers
209 papers, 11.9k citations indexed

About

Suowen Xu is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, Suowen Xu has authored 209 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Molecular Biology, 53 papers in Immunology and 31 papers in Physiology. Recurrent topics in Suowen Xu's work include Atherosclerosis and Cardiovascular Diseases (28 papers), Traditional Chinese Medicine Analysis (18 papers) and Sirtuins and Resveratrol in Medicine (16 papers). Suowen Xu is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (28 papers), Traditional Chinese Medicine Analysis (18 papers) and Sirtuins and Resveratrol in Medicine (16 papers). Suowen Xu collaborates with scholars based in China, United States and Australia. Suowen Xu's co-authors include Peter J. Little, Peiqing Liu, Jianping Weng, Danielle Kamato, Iqra Ilyas, Zheng Gen Jin, Zhiping Liu, Xiaojun Feng, Zhuo-ming Li and Amirhossein Sahebkar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Suowen Xu

202 papers receiving 11.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

2021 686 citations Suowen Xu, Iqra Ilyas et al. profile →
Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering

2018 453 citations Seyed Mohammad Nabavi, Dunja Šamec et al. Biotechnology Advances profile →
Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics

2018 393 citations Suowen Xu et al. Acta Pharmacologica Sinica profile →
Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics

2019 323 citations Xiaojun Feng, Antonio García‐Ríos et al. profile →
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics

2022 261 citations Yajun Duan, Suowen Xu et al. Signal Transduction and Targeted Therapy profile →
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

2022 234 citations Suowen Xu, Iqra Ilyas et al. Acta Pharmacologica Sinica profile →
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

2021 188 citations Xiaoxuan Ma, Zhenghong Liu et al. International Journal of Biological Sciences profile →
Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis

2022 150 citations Hui Jiang, Seyed Mohammad Nabavi et al. profile →
Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies

2023 142 citations Peter J. Little, Suowen Xu et al. Signal Transduction and Targeted Therapy profile →

Peers

Suowen Xu

IMMUN

CAM

EPIDE

Peiqing Liu China

Guang Liang China

Jong‐Sup Bae South Korea

Ramaroson Andriantsitohaina France

Luyong Zhang China

Ying‐Yong Zhao China

Shu‐Feng Zhou China

Joohun Ha South Korea

Jinyong Peng China

William P. Steward United Kingdom

Peiqing Liu China

Suowen Xu

6.3k ×1.2

1.4k ×0.7

IMMUN

1.8k ×1.3

CAM

1.2k ×0.9

EPIDE

1.2k ×0.9

Citations per year, relative to Suowen Xu Suowen Xu (= 1×) peers Peiqing Liu

Countries citing papers authored by Suowen Xu

Since Specialization

Citations

This map shows the geographic impact of Suowen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suowen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suowen Xu more than expected).

Fields of papers citing papers by Suowen Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suowen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suowen Xu. The network helps show where Suowen Xu may publish in the future.

Co-authorship network of co-authors of Suowen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Suowen Xu. A scholar is included among the top collaborators of Suowen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suowen Xu. Suowen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Yaqi, Dingwei Zhao, Qian Ma, et al.. (2025). Endothelial adenosine receptor 2A loss alleviates diabetic vascular calcification by blocking CREB1-SNAI1-driven EndMT. Pharmacological Research. 221. 107981–107981.

Bowden, Neil, Céline Souilhol, Hisham M. Darwish, et al.. (2025). Endothelial c-REL orchestrates atherosclerosis at regions of disturbed flow through crosstalk with TXNIP-p38 and non-canonical NF-κB pathways. Cardiovascular Research. 121(5). 748–759. 2 indexed citations

Wang, Zhihua, et al.. (2025). Prioritization of Lipid Metabolism Targets for the Diagnosis and Treatment of Cardiovascular Diseases. Research. 8. 618–618. 3 indexed citations

Jin, Hongfang, Zhidan Zhang, Li Wang, et al.. (2025). Colchicine Inhibits Smooth Muscle Cell Phenotypic Switch and Aortic Dissection in Mice—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 45(6). 979–984. 1 indexed citations

Zhou, Yaqi, Qiuhua Yang, Jiean Xu, et al.. (2024). Blockade of endothelial adenosine receptor 2 A suppresses atherosclerosis in vivo through inhibiting CREB-ALK5-mediated endothelial to mesenchymal transition. Pharmacological Research. 203. 107156–107156. 10 indexed citations

Wang, Qiuping, Kui Chen, Hui Jiang, et al.. (2023). Cell-inspired design of cascade catalysis system by 3D spatially separated active sites. Nature Communications. 14(1). 5338–5338. 35 indexed citations

Gao, Si, Xueping Liu, Li Chen, et al.. (2023). Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery. Acta Pharmacologica Sinica. 45(1). 23–35. 21 indexed citations

Xu, Jing-Jing, Xiaohua Jiang, & Suowen Xu. (2023). Aprocitentan, a dual endothelin-1 (ET-1) antagonist for treating resistant hypertension: Mechanism of action and therapeutic potential. Drug Discovery Today. 28(11). 103788–103788. 8 indexed citations

Xu, Suowen, et al.. (2023). ASGR1: an emerging therapeutic target in hypercholesterolemia. Signal Transduction and Targeted Therapy. 8(1). 43–43. 13 indexed citations

10.

Kang, Lijing, Chi‐Wai Lau, Lei He, et al.. (2023). AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation. Antioxidants. 12(9). 1681–1681. 7 indexed citations

11.

Zhu, Mengmeng, Shengnan Wang, Tingting Zhang, et al.. (2023). Transcription factor 21 accelerates vascular calcification in mice by activating the IL-6/STAT3 signaling pathway and the interplay between VSMCs and ECs. Acta Pharmacologica Sinica. 44(8). 1625–1636. 20 indexed citations

12.

Wu, Xiaoqian, Huan Liu, Suowen Xu, et al.. (2022). SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes. Circulation Research. 131(11). 926–943. 56 indexed citations

13.

Chen, Meijie, Jianbo Xiao, Hesham R. El‐Seedi, et al.. (2022). Kaempferol and atherosclerosis: From mechanism to medicine. Critical Reviews in Food Science and Nutrition. 64(8). 2157–2175. 62 indexed citations

14.

Ghasemi, Sorayya, Suowen Xu, Seyed Mohammad Nabavi, et al.. (2021). Epigenetic targeting of cancer stem cells by polyphenols (cancer stem cells targeting). Phytotherapy Research. 35(7). 3649–3664. 17 indexed citations

15.

Devi, Kasi Pandima, Tarun Belwal, Hari Prasad Devkota, et al.. (2021). Harnessing polyphenol power by targeting eNOS for vascular diseases. Critical Reviews in Food Science and Nutrition. 63(14). 2093–2118. 20 indexed citations

16.

Ma, Xiaoxuan, Zhenghong Liu, Iqra Ilyas, et al.. (2021). GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential. International Journal of Biological Sciences. 17(8). 2050–2068. 188 indexed citations breakdown →

17.

Zhang, Shengyu, et al.. (2020). Natural products: The role and mechanism in low‐density lipoprotein oxidation and atherosclerosis. Phytotherapy Research. 35(6). 2945–2967. 65 indexed citations

18.

Nabavi, Seyed Mohammad, Kasi Pandima Devi, A. Sanches‐Silva, et al.. (2020). New Trends in the Pharmacological Intervention of PPARs in Obesity: Role of Natural and Synthetic Compounds. Current Medicinal Chemistry. 28(20). 4004–4022. 5 indexed citations

19.

Khan, Haroon, Tarun Belwal, Thomas Efferth, et al.. (2020). Targeting epigenetics in cancer: therapeutic potential of flavonoids. Critical Reviews in Food Science and Nutrition. 61(10). 1616–1639. 62 indexed citations

20.

Nabavi, Seyed Mohammad, Dunja Šamec, Michał Tomczyk, et al.. (2018). Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering. Biotechnology Advances. 38. 107316–107316. 453 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact